Evidence map›Paper›PMID 35460310›Full record

Trial reportJournal of cosmetic dermatology2023

Anti-wrinkle properties of Angelica gigas Nakai root extracts using mineral-rich water.

Jung-Wook Kang, Hang-Eui Cho, Ho-Min Choi, In-Chul Lee

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cosmetic dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Advancing the Potential ofPlants (Basel, Switzerland) · 2026
    Article
  3. Autophagy-Enhancing Properties ofMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jung-Wook KangCollege of Fusion and Convergence, Seowon University, Cheongju, Korea.
Hang-Eui ChoCreative Innovation Research Center, Cosmecca Korea, Co. Ltd., Seongnam-si, Korea.
Ho-Min ChoiDurae Corporation, Jeju Bio Center, Jeju-si, Korea.
In-Chul LeeDepartment of Cosmetic Science and Technology, Seowon University, Cheongju, Korea.
Seowon University · KRCreative Research · GBJeju TechnoPark · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAngelica gigas Nakai is used as an herbal pharmaceutical material in Korea.

aimsTo investigate the anti-wrinkle effects of A. gigas Nakai root extracts (ARE) using mineral-rich water in in vitro and clinical trials. MATERIALS AND

methodsThe cell viability of ARE was evaluated using a water-soluble tetrazolium salt assay. After evaluating ARE's cytotoxicity, we used an enzyme-linked immunosorbent assay kit to assess the effects of ARE on type I collagen in human dermal fibroblasts (HDFs). During a double-blinded in vivo clinical study, participants were randomly assigned to use the sample and placebo formulations for the left and right sides of their face over an 8-week period. We evaluated the anti-wrinkle properties of the formulations using PRIMOS Lite and a global photodamage score.

resultsA. gigas Nakai root extracts cytotoxicity was evaluated in HDFs. We demonstrate that ARE increased type I collagen production by 40% at 50 μg/ml as compared with the control. The use of an ARE lotion significantly reduced the presence of crow's feet wrinkles in comparison with the use of the placebo after 8 weeks. Additionally, use of the ARE lotion led to decreased photodamage scores, indicating anti-wrinkle effects.

conclusionThe use of ARE with mineral-rich water has anti-wrinkle effects in in vitro and clinical trials.

Indexed as

AngelicaMineral WatersSkin AgingCollagen Type IDouble-Blind MethodHumansMineralsPlant ExtractsCollagen Type IMineralsMineral WatersPlant ExtractsAngelica gigas Nakai root extractsanti-wrinkle effectsin vitroin vivomineral-rich water

Identifiers

PMID35460310
PMCPMC10084234
OpenAlexW4224310404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.